TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 4 | 3 | 22 | 44 | 93 | 149 | 53 |
| P | %wins | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/16/08 17:52 | 4/15/08 | NILT | Nile Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schafer Gregory W | CA | D | P | 0 | 4.60 | 0 | 0 | New | 0 | D | |||||||||||||||
8/15/06 13:54 | 8/11/06 | ONXX | Onyx Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Schafer Gregory W | CA | O | CFO | P | 33 | 13.36 | 12 | 3 | New | 3 | D | -59 | -36 | -53 | -39 | -22 | -16 | -20 | -6 | 4 | 3 | 22 | 44 | 93 | 149 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |